Building a team of passionate visionaries to bring new hope to millions
At Reactive, we’re using the world’s leading boron-based discovery platform to discover and develop medicines in innovative and imaginative new ways.
By utilizing boron’s unique characteristics to access novel binding sites, we’re looking to advance therapeutics in areas previously thought to be undruggable. Our goal is to make impactful medicines that can truly change the course of disease—and the lives of patients and their loved ones.
Leadership team
Julie Grant
CEO
Steve Baker
Head of Chemistry
Tony Liu
Head of Platform
Peter Farina
Head of Pre-Clinical & Structural Biology
Esther van den Boom
Head of Finance
Jake Plattner
Senior Scientific Fellow
Scientific founders
Stephen Benkovic
Scientific Founder
Paul Schimmel
Scientific Founder
Lucy Shapiro
Scientific Founder
Partnering for innovation
Reactive is pursuing partnerships with companies interested in using our platform for accelerating the discovery and development of transformational medicines for patients. Please reach out to us to discuss potential synergies.